Abbott Laboratories (ABT)

ABT (NYSE:Health Services) EQUITY
$37.91
pos +0.00
+0.00%
Today's Range: 37.91 - 38.56 | ABT Avg Daily Volume: 9,790,000
Last Update: 06/24/16 - 4:01 PM EDT
Volume: 0
YTD Performance: -15.59%
Open: $0.00
Previous Close: $39.63
52 Week Range: $36.00 - $51.74
Oustanding Shares: 1,469,152,033
Market Cap: 58,222,495,068
6-Month Chart
TheStreet Ratings Grade for ABT
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 10 9 9 10
Moderate Buy 2 2 2 2
Hold 4 4 5 5
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.63 1.67 1.75 1.71
Latest Dividend: 0.26
Latest Dividend Yield: 2.62%
Dividend Ex-Date: 07/13/16
Price Earnings Ratio: 28.11
Price Earnings Comparisons:
ABT Sector Avg. S&P 500
28.11 24.50 12.90
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-6.97% -23.41% 8.41%
GROWTH 12 Mo 3 Yr CAGR
Revenue 0.80 -0.50 -0.20
Net Income 93.70 -0.60 -0.24
EPS 96.00 -0.20 -0.08
Earnings for ABT:
EBITDA 4.34B
Revenue 20.41B
Average Earnings Estimates
Qtr (06/16) Qtr (09/16) FY (12/16) FY (12/17)
Average Estimate $0.53 $0.59 $2.20 $2.48
Number of Analysts 11 9 14 14
High Estimate $0.54 $0.60 $2.23 $2.57
Low Estimate $0.52 $0.58 $2.19 $2.40
Prior Year $0.52 $0.54 $2.15 $2.20
Growth Rate (Year over Year) 1.75% 9.88% 2.43% 12.75%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
The M&A activity is an incredible and a welcome sign.
Movement has become difficult after weeks of advances, which suggests a downturn may be near.
This stock is well into overbought territory.
The Russell 2000's failure to follow the S&P and Dow's lead is only one reason for concern.
Bearish
Jan 29, 2016 | 7:21 AM EST
ABT was downgraded to Market Perform, William Blair said. Company continues to face earnings headwinds. 
Two significant, but subtle forces may threaten the group in the next 12 months.
The merged company can become multiple companies.
Bullish
Dec 07, 2015 | 7:24 AM EST
ABT was upgraded from Hold to Buy, Jefferies said. $55 price target. Growth platforms are likely to remain strong in emerging markets.&...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.